SNP arrays, low-pass WGS, and deep WGS each offer different trade-offs for population genomics. This article compares these platforms in terms of cost, data quality, GWAS and PRS performance, and rare variant detection across human, plant, and animal studies. Use it as a practical guide to design a cost-effective population sequencing strategy and to decide when to combine arrays, low-pass WGS, and deep WGS in one research project.
Choosing between SNP arrays, low-pass WGS, and deep WGS is one of the most important decisions in any population genomics project. This single choice shapes your total budget, sample size, statistical power, and even which biological questions you can answer.
For many teams, the situation looks like this:
At the same time, sequencing options are expanding. Studies in human and livestock cohorts have shown that low-pass whole-genome sequencing (often 0.1–2× depth) plus imputation can rival or outperform many SNP arrays for common variant GWAS in diverse populations. Deep WGS remains the reference standard for rare and structural variants, but is harder to scale to tens of thousands of samples.
This article walks through how SNP arrays, low-pass WGS, and deep WGS compare in population genomics. It focuses on practical design choices, real-world trade-offs, and how to connect platform selection with downstream GWAS analysis, PRS evaluation, and population genetics analysis. The goal is not to promote one technology in isolation, but to help you design a cost-effective population sequencing strategy that fits your cohort, species, and budget.
Understanding what each platform actually does is the first step towards a rational study design. This section provides short, clear definitions that can stand alone as direct answers to "What are SNP arrays?" or "What is low-pass WGS?" in a population genomics setting.
SNP arrays are fixed panels of pre-selected genetic markers that provide genotypes at known positions across the genome.
In population genomics, SNP genotyping array services are widely used because they combine relatively low per-sample cost with mature, well-understood workflows. Arrays work especially well for:
However, arrays only capture variants present on the chip. They offer limited coverage of novel variants, rare alleles, and structural variants. Chip content may also be biased toward certain ancestries or breeds, which can affect performance in diverse cohorts.
Comparison of derived allele frequency spectra from whole-genome sequencing and various SNP array-derived marker sets, illustrating the underrepresentation of rare variants introduced by array design decisions (Geibel J. et al. (2021) PLOS ONE).
Low-pass whole-genome sequencing (low-pass WGS) is shallow whole-genome sequencing, typically around 0.1–4× coverage per sample, combined with genotype imputation.
Instead of reading every base many times, low-pass WGS lightly samples the entire genome and then uses a reference panel to infer dense genotypes. When the reference panel is appropriate for the target population, low-pass WGS can reach imputation accuracy similar to, or better than, many SNP arrays for common variants.
Low-pass WGS is especially attractive when:
Because it captures variation across the whole genome, low-pass WGS fits naturally with population WGS sequencing services, GWAS analysis services, and PRS analysis in large-scale population studies.
Deep WGS is high-coverage whole-genome sequencing, usually 20–30× or higher, designed to capture nearly all variants in a genome with high confidence.
Deep WGS supports:
Because deep WGS is still more expensive per sample and generates large data volumes, it is often reserved for smaller cohorts or for subsets of larger cohorts. Many successful population genomics projects combine deep WGS on a subset with lower-cost genotyping of the remaining samples.
All three approaches deliver genotype information, but they do so with different cost structures and scientific strengths. A simple comparison helps you see when each option is the better tool for your study.
A conceptual summary looks like this:
| Dimension | SNP arrays | Low-pass WGS | Deep WGS |
| Typical coverage | Fixed SNP sites only | ~0.1–4× whole genome | ≥20–30× whole genome |
| Upfront cost per sample | Low | Moderate (dropping over time) | Highest |
| Common variant GWAS | Strong | Strong (with good reference panel) | Strong |
| PRS, cross-ancestry | Variable, chip-dependent | Strong, genome-wide coverage | Strong |
| Rare SNVs and indels | Limited | Partial, depth- and panel-dependent | Best |
| Structural variants | Very limited | Limited | Best |
| Suitability for non-model spp. | Limited by chip availability | Good, panel-dependent | Good, cost-dependent |
| Data reusability | Moderate | High | Very high |
This table is not a rigid rulebook; it is a starting point for discussion before detailed costing and power calculations.
For a fixed total budget, arrays typically support the largest sample sizes, followed by low-pass WGS, then deep WGS. In many human projects, a mid-density SNP array may allow you to genotype two to three times more samples than deep WGS at current prices, though exact ratios depend on local costs and sequencing platform.
Low-pass WGS sits in the middle. Per-sample cost is usually higher than a mid-density chip, but substantially lower than 30× WGS. Studies in human cohorts, cattle, pigs, and aquaculture species have shown that low-pass WGS offers a favourable balance between cost and genomic coverage for population genotyping.
When you design a cost-effective population sequencing strategy, it is often more useful to think in terms of "cost per effective genotype" and "cost per unit of power" rather than only "cost per sample".
From an analysis perspective:
Fraction of non-monomorphic variants captured by ultra low-coverage WGS compared with an imputed SNP array across minor allele frequency bins, using 30× WGS as a reference in a melanoma cohort (Chat V. et al. (2021) Frontiers in Genetics).
These patterns matter as much as list prices when selecting SNP arrays vs low-pass or deep WGS.
Rather than starting from a favourite technology, it is usually more effective to start from the scientific questions you want to answer. This section frames designs by goal, then maps those goals to practical combinations of SNP arrays, low-pass WGS, and deep WGS.
If your primary goal is common variant GWAS and PRS in a large human cohort, SNP arrays and low-pass WGS are both realistic choices.
A pragmatic approach is:
Use SNP arrays when:
Use low-pass WGS when:
For teams running multi-centre or international studies, low-pass WGS can reduce dependency on a specific chip and avoid problems when different sites use slightly different array products. This makes low-pass WGS an attractive backbone for population genomics sequencing services and PRS analysis services in global cohorts.
If your main interest is rare coding variants, loss-of-function alleles, or complex structural variants, deep WGS usually offers the best value, even if you can only sequence a smaller number of samples.
A common hybrid strategy is:
This kind of design can align well with integrated services that combine whole-genome sequencing, rare variant detection, and GWAS analysis in a single project plan.
Plant and animal breeding projects often start from legacy SNP arrays or reduced-representation methods such as GBS. In these settings, low-pass WGS provides a way to upgrade genomic coverage while reusing earlier data.
A practical, phased pattern looks like this:
This staged approach helps breeding teams pilot low-pass WGS while controlling risk and maintaining continuity with historical data. It fits naturally with agricultural genomics services, population sequencing services for livestock and crops, and population genetics services for non-model species.
Platform choice is important, but practical details often decide whether a project works smoothly in real life. Many issues arise not from arrays or WGS themselves, but from sample quality, reference panel mismatch, or underestimating compute and storage needs.
Across all platforms, robust quality control is more important than squeezing out a little more coverage or marker density. Successful population studies generally:
Ignoring these basics can reduce GWAS power, inflate false positives, or bias PRS models. In our experience, projects that invest time in a clear QC plan at the start spend much less time troubleshooting later.
Low-pass WGS and array-based imputation both depend heavily on reference panels. When the panel reflects the target population, imputation can reach high accuracy even at relatively low coverage. When it does not, accuracy drops, especially for rare and population-specific variants.
Before committing to a design, it is worth asking:
In some projects, the cost of deep WGS for a few hundred reference samples is justified by the gains in imputation accuracy and analytic power in a much larger low-pass WGS or array cohort. This is especially relevant for underrepresented human ancestries and for non-model species.
Imputation R² values for ultra low-coverage WGS across allele frequency bins, showing higher imputation certainty than an imputed SNP array for both SNPs and indels at common and low-frequency variants (Chat V. et al. (2021) Frontiers in Genetics).
Arrays, low-pass WGS, and deep WGS differ in data volume and computational requirements:
For population-scale work, it is important to check that you have access to:
Underestimating these needs can delay downstream results even when sequencing itself goes smoothly.
CD Genomics can help you turn high-level study ideas into a concrete, cost-effective population sequencing strategy. Rather than choosing between SNP arrays, low-pass WGS, and deep WGS in isolation, you can work with a team that sees the full pipeline from study design to variant interpretation.
Many clients approach us with a rough plan, such as "about 10,000 samples from a mixed-ancestry human cohort" or "a multi-year breeding programme with several thousand animals per year." Our first step is to translate those plans into comparable scenarios:
We then discuss trade-offs in sample size, cost per sample, and analytic power for GWAS, PRS, and rare variant analyses. Where possible, we refer to published benchmarks and our own aggregated project experience, while keeping individual project data confidential.
This consultation stage connects directly to our population sequencing services, whole genome sequencing service, and SNP array genotyping service offerings.
Once a design is agreed, CD Genomics can manage the laboratory and analytical workflow under a single project structure:
All steps are documented, and QC reports are shared so you can track coverage, call rates, and imputation performance against predefined thresholds. This allows your internal team to focus more on biological interpretation and decision-making.
Different teams need different levels of support. Some clients ask CD Genomics to handle only the lab work and deliver aligned reads or joint-called variants. Others request complete sequencing and bioinformatics analysis service packages, including structured result summaries for internal stakeholders.
Typical collaboration models include:
In each case, platform choice is treated as part of an evolving strategy that adapts to your scientific questions and resources.
To help you decide whether to involve CD Genomics, it can be useful to walk through a short checklist:
This process turns a complex "SNP arrays vs low-pass and deep WGS" debate into a structured, data-informed decision.
To discuss your project or request a tailored population sequencing strategy, you can contact CD Genomics and share a brief description of your cohort, goals, and constraints.
No. Low-pass WGS can match or exceed arrays in many common variant GWAS and PRS settings, especially when reference panels are strong and ancestries are diverse. However, well-designed SNP arrays may still be more cost-effective if a suitable chip exists for your population and your main goal is large-sample GWAS without rare variant analysis.
Most low-pass WGS designs use coverage between about 0.1× and 4× per sample, followed by genotype imputation. Depth near 0.5–2× is a common compromise between cost and accuracy, though the ideal range depends on your reference panel, species, and analytic goals.
Not necessarily. If your main interest is rare variants, you usually need deep WGS for at least a subset of samples, but you can combine that with arrays or low-pass WGS in the remainder of the cohort. The deep WGS subset can support reference panel construction and targeted rare variant analyses, while the larger cohort boosts power for common variant GWAS.
Reference panels are critical. Imputation accuracy depends strongly on how similar the panel is to your target population and how many haplotypes it contains. When panels are small or ancestry-mismatched, accuracy drops, especially for rare variants and local haplotypes. In such cases, building an internal panel with deep WGS on a subset of samples can be a worthwhile investment.
You may benefit from external support when you are comparing several design options, when your cohort includes underrepresented ancestries or non-model species, or when your internal team cannot maintain large-scale GWAS, imputation, and population genetics pipelines. In these situations, discussing your draft plan with a partner can prevent costly redesigns later and help you choose between SNP arrays, low-pass WGS, and deep WGS with greater confidence.
Related Reading:
References